Professional Documents
Culture Documents
Stephen Bevan
The Work Foundation
Wednesday 30 September
2009
Fit for Work - Questions
What is the Problem?
Why Does this Matter?
What questions have we asked?
How did we gather our evidence?
What answers did we find?
What should be done and by whom?
What Next?
What is the Problem?
The MSD Problem
• Over 100m Europeans have Chronic Musculoskeletal Pain at some time in
their lives – more than 4 in ten of whom never get diagnosed.
• Over 40m European workers have MSDs caused by their work which affect
their job performance or their labour market status.
• MSDs include over 200 complaints such as back pain, WRULDs and other
conditions of the bones, joints and connective tissue
• This costs the EU over 240 billion Euros each year in direct costs of treatment,
absence from work and lost productivity
• We know what to do about this problem but the EC, National Governments,
Employers, Healthcare systems and Social security systems are not currently
capable of coordinating their efforts to reduce the economic and social burden
of MSDs.
• What is more, in most countries the MSD problem will get worse before it gets
better – especially as the population ages and as obesity increases.
Why does this Matter?
So What?
• We need a workforce which is Fit for Work post-recession – ill-
health in the working age population is economically inefficient
and socially corrosive.
• Once a worker – especially a worker with a long-term or chronic
health condition – loses their place in the labour market, it is
very difficult for them to return.
• This is an avoidable waste of human capital and productive
capacity which affects our competitiveness, social and
community cohesion and family stability.
What questions have we asked?
Core Study Questions
• How big is the MSD problem in Europe? What are its causes, costs
and consequences?
• Are there good examples of policy and practice which might give us
hope that something positive & sustainable can be done to improve
the position of workers with MSDs?
• What kinds of interventions can make most difference and what is the
evidence for their clinical, labour market, economic and social
benefits?
• Can early intervention yield a ‘premium’ for individuals, the economy &
society?
• What should the EC, National Governments, employers, clinicians,
workers and their representatives do to ensure that the impact of
MSDs is minimised?
How did we gather our evidence?
Our Methods
• Extensive reviews of published and unpublished research in
each country
• Collation of prevalence and cost data from National sources and
cross-country clinical and labour market studies
• Interviews with economists, labour market experts, clinicians,
patient groups and policy-makers
• Econometric data analysis
• Reports in 24 Countries in Europe & beyond
What answers did we find?
Findings
• MSDs cause more days lost from work, among more European workers, that
any other health condition – including ‘stress’ or mental health.
• Despite less physical work in modern workplaces, work-related MSDs are still
the dominant cause of absence – lifestyle and other factors are key
• Many workers with MSDs develop Mental Health problems too – this means that
treating the physical causes & symptoms by themselves will only rarely be
enough
• Not all MSDs are caused by work. Rheumatic and inflammatory conditions of
the bones and joints affect millions of workers but, because their conditions are
not caused by work, they are largely ignored by EU policymakers and by many
National Governments.
• Policy & practice in most countries have several weaknesses including, poor
data, poor co-ordination between government agencies, ignorance or fear
among employers, clinicians who do not see Return To Work as a clinical
outcome,
• Early diagnosis & intervention can make a difference to labour market
participation and yield an economic ‘premium’
Examples
• Belgium
– Direct and indirect costs of absence rose from €8.2 bn in 2006 to €10.35 bn
in 2008: 40% of absence is attributable to musculoskeletal problems
• Italy
– >23m days of work lost every year due to specific MSDs not caused by work
– 27% of workers provide care for elderly/disabled family member: costs of
MSDs should also include this loss of productivity
• UK
– 33% suffer with back pain and up to 80 per cent of the adult population will
suffer significant back pain
– Cost of MSDs per year estimated at £7bn per year
Injury
Disability
Disuse
Avoidance Depression Recovery
Painful Experiences
Fear of movement
or re-injury Confrontation
Catastrophising Non-catastrophising